Observational studyThe journal of headache and pain2025

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response.

Albert Muñoz-Vendrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.